DE60237111D1 - "feste dosierungsform zur okularen applikation einer wirksubstanz, lösliche, feste ophthalmische einlage sowie herstellungsverfahren dafür" - Google Patents

"feste dosierungsform zur okularen applikation einer wirksubstanz, lösliche, feste ophthalmische einlage sowie herstellungsverfahren dafür"

Info

Publication number
DE60237111D1
DE60237111D1 DE60237111T DE60237111T DE60237111D1 DE 60237111 D1 DE60237111 D1 DE 60237111D1 DE 60237111 T DE60237111 T DE 60237111T DE 60237111 T DE60237111 T DE 60237111T DE 60237111 D1 DE60237111 D1 DE 60237111D1
Authority
DE
Germany
Prior art keywords
solid
soluble
manufacturing
method therefor
effective application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60237111T
Other languages
English (en)
Inventor
Meski Said El
Philippe Tourrette
Jean-Marc Aiache
Battista Marie Di
Gilbert Serpin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Thea SAS
Original Assignee
Ioltechnologie Production SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8870629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60237111(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ioltechnologie Production SARL filed Critical Ioltechnologie Production SARL
Application granted granted Critical
Publication of DE60237111D1 publication Critical patent/DE60237111D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60237111T 2001-12-18 2002-12-17 "feste dosierungsform zur okularen applikation einer wirksubstanz, lösliche, feste ophthalmische einlage sowie herstellungsverfahren dafür" Expired - Lifetime DE60237111D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116377A FR2833493B1 (fr) 2001-12-18 2001-12-18 Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
PCT/FR2002/004384 WO2003051330A1 (fr) 2001-12-18 2002-12-17 Forme galenique solide pour l'administration oculaire de principe actif, insert ophtalmique solide et soluble et procede de fabrication d'un tel insert

Publications (1)

Publication Number Publication Date
DE60237111D1 true DE60237111D1 (de) 2010-09-02

Family

ID=8870629

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60237111T Expired - Lifetime DE60237111D1 (de) 2001-12-18 2002-12-17 "feste dosierungsform zur okularen applikation einer wirksubstanz, lösliche, feste ophthalmische einlage sowie herstellungsverfahren dafür"

Country Status (12)

Country Link
US (1) US8663678B2 (de)
EP (1) EP1465594B1 (de)
JP (1) JP4917738B2 (de)
CN (1) CN1615120B (de)
AT (1) ATE474552T1 (de)
AU (1) AU2002364658A1 (de)
CA (1) CA2470377C (de)
DE (1) DE60237111D1 (de)
ES (1) ES2349295T3 (de)
FR (1) FR2833493B1 (de)
PT (1) PT1465594E (de)
WO (1) WO2003051330A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2414193C2 (ru) * 2005-07-29 2011-03-20 Сантен Фармасьютикал Ко., Лтд. Неинвазивная система доставки лекарственного средства к ткани заднего сегмента глаза с применением твердой композиции
US9877973B2 (en) * 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
MX2016004257A (es) * 2013-10-03 2016-08-17 Imprimis Pharmaceuticals Inc Composiciones oftalmicas basadas en epinefrina para la administracion intraocular y metodos para su frabricacion.
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ2015398A3 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
EP3108874A1 (de) * 2015-06-26 2016-12-28 TRB Chemedica AG Pharmazeutische zubereitung zur anwendung am auge
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
CN106074361B (zh) * 2016-07-14 2018-10-19 何伟 一种抗眼内炎症植入剂及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993071A (en) * 1971-09-09 1976-11-23 Alza Corporation Bioerodible ocular device
US4179497A (en) * 1973-12-17 1979-12-18 Merck & Co., Inc. Solid state ophthalmic medication
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4518433A (en) * 1982-11-08 1985-05-21 Fmc Corporation Enteric coating for pharmaceutical dosage forms
IT1223150B (it) * 1987-11-18 1990-09-12 Ubaldo Conte Compressa per uso oftalmico e rilascio controllato della sostanza attiva
IE920040A1 (en) * 1991-01-09 1992-07-15 Alza Corp Bioerodible devices and compositions for diffusional release¹of agents
FR2688694B1 (fr) * 1992-03-20 1999-06-25 Vetoquinol Sa Insert ophtalmique bioadhesif.
AU5092493A (en) * 1992-09-08 1994-03-29 Allergan, Inc. Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
JPH08127533A (ja) * 1994-11-01 1996-05-21 Taisho Pharmaceut Co Ltd 内服固形製剤用組成物
EP0903151A1 (de) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Verwendung von Kombinationen enthaltend nichtsedierende Antihistaminika und Alfa-Adrenergische Agonisten für die topische Behandlung von Rhinitis/Konjunktivitis sowie Erkältungs- und Grippe-Symptomen
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
JP4828678B2 (ja) * 1998-11-18 2011-11-30 武田薬品工業株式会社 圧縮成形物
JP2001081048A (ja) * 1999-09-10 2001-03-27 Wakamoto Pharmaceut Co Ltd 眼圧降下剤
JP3435664B2 (ja) * 1999-12-08 2003-08-11 ヤンセンファーマ株式会社 口腔内速崩壊型錠剤及びその製造方法
US6548535B2 (en) * 2000-01-18 2003-04-15 Merck & Co., Inc. Method for treating ocular hypertension
DE10007203A1 (de) * 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis

Also Published As

Publication number Publication date
CA2470377C (fr) 2013-09-17
AU2002364658A1 (en) 2003-06-30
PT1465594E (pt) 2010-10-27
CA2470377A1 (fr) 2003-06-26
JP2005516922A (ja) 2005-06-09
FR2833493B1 (fr) 2005-09-23
ATE474552T1 (de) 2010-08-15
WO2003051330A1 (fr) 2003-06-26
EP1465594B1 (de) 2010-07-21
FR2833493A1 (fr) 2003-06-20
CN1615120A (zh) 2005-05-11
US20050118231A1 (en) 2005-06-02
US8663678B2 (en) 2014-03-04
JP4917738B2 (ja) 2012-04-18
EP1465594A1 (de) 2004-10-13
CN1615120B (zh) 2012-09-19
ES2349295T3 (es) 2010-12-29

Similar Documents

Publication Publication Date Title
WO2003002243A3 (en) Method and device for electrochemical formation of therapeutic species in vivo
WO2006017470A3 (en) Device and method for treating a vessel
WO2001032121A3 (en) Skin-gripper
ES2082723B1 (es) Formulacion farmaceutica de fluoxetina en forma dispersable.
CO5150154A1 (es) Composicion de sustrato y metodo para usarlo para el secuestro de irritantes de la piel
HK1061975A1 (en) Novel method and compostions for local treatment of meniere's disease, tinnitus and/or hearing loss
CA2363990A1 (en) Use of glycyrrhizin in the treatment of mastitis
DE60237111D1 (de) "feste dosierungsform zur okularen applikation einer wirksubstanz, lösliche, feste ophthalmische einlage sowie herstellungsverfahren dafür"
CA2321560A1 (en) The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
RU2008102249A (ru) Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания
CA2225398A1 (en) Pharmaceutical composition comprising albumin as an active ingredient
WO2003094905A8 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
CO5280202A1 (es) Metodos de tratamiento y metodos de rastreo de farmacos
MXPA03010363A (es) Metodo para tratar hipertension ocular y glaucoma.
PT1067907E (pt) Solucao para irrigacao ocular
EP1228761A3 (de) Flüssige pharmazeutische Zusammensetzung zur Behandlung von Knochenerkrankungen
NO20003283D0 (no) Natriumion-absorpsjonsinhibitorer, natriumion- utskillingsakseleratorer, og forebyggende og terapeutiske midler for sykdommer som følger av overdrevent inntak av koksalt
WO2002096317A3 (en) Method for treating glaucoma vi
RU97116792A (ru) Способ лечения эрозий роговицы после эксимерлазерной фоторефракционной кератэктомии
RU99120817A (ru) Способ лечения заболеваний и повреждений передней поверхности глаза
RU2002120292A (ru) Способ лечения бессонницы неорганической этиологии
RU98102114A (ru) Способ лечения острых воспалительных заболеваний женских половых органов
RU96120520A (ru) Способ снятия алкогольной зависимости и.в.кривопалова-москвина
RU99104892A (ru) Способ защиты внутренних структур глаза от ультразвукового воздействия при факоэмульсификации
RU2000103081A (ru) Способ апинаркотерапии

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRES THEA, CLERMONT-FERRAND, FR